ATR AptarGroup, Inc.

NYSE · US · Healthcare · Medical Instruments & Supplies · aptar.com

120.61USD+0.58%Mkt Cap: 7.67B $P/E: 21.771d ago

AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care,…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc.

$143.60BUSDP/E 46.6

EssilorLuxottica Société anonyme

$72.05BUSDP/E 27.0

BDX

Becton, Dickinson and Company

West Pharmaceutical Services, Inc.

$26.51BUSDP/E 48.2

DIM

Sartorius Stedim Biotech S.A.

$22.21BUSDP/E 69.8

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$15.16BUSDP/E 71.4

SOLV

Solventum Corporation

$14.98BUSDP/E 10.8

BAX

Baxter International Inc.

$12.52BUSD

COO

The Cooper Companies, Inc.

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

ALGN

Align Technology, Inc.

$9.99BUSDP/E 24.5

BLCO

Bausch + Lomb Corporation

$6.13BUSD

Key Statistics

Company

Market Cap7.67B USD

Enterprise Value8.88B USD

Revenue (TTM)3.93B USD

Gross Profit1.40B USD

Net Income (TTM)392.79M USD

Revenue/Share60.89 USD

Last Price120.61 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees14.0K

CountryUS

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)21.77

P/E (Forward)19.02

PEG2.50

EV/EBITDA11.13

EV/Revenue2.26

P/S1.94

P/B2.90

EPS (TTM)5.54

EPS (Forward)6.30

52W Range

103.2340% of range146.91

52W High146.91 USD

52W Low103.23 USD

Profitability

Gross Margin37.19%

Oper. Margin12.49%

EBITDA Margin20.30%

Profit Margin10.40%

ROE14.72%

ROA7.48%

Growth

Revenue Growth6.30%

Earnings Growth-18.60%

Cash Flow & Leverage

Operating CF570.00M USD

CapEx (TTM)275.44M USD

FCF Margin6.76%

FCF Yield3.47%

Net Debt1.21B USD

Net Debt/EBITDA1.52

Balance Sheet

Debt/Equity0.57

Current Ratio1.61

Quick Ratio0.98

Book Value/Sh41.33 USD

Cash/Share3.10 USD

Dividends

Fwd Div Rate1.92 USD

Trail. Div Rate1.89 USD

Div. Yield1.60%

5Y Avg Yield1.28%

Payout Ratio34.12%

Ex-Div DateJul 30, 2026

Pay DateAug 20, 2026

Splits

Last Split2:1

Split DateMay 10, 2007

Analyst Consensus

Rating1.5 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)170.14 USD

Upside (mean)+41.1%

Target Range155.00 USD – 220.00 USD

155.00+41.1% to mean220.00

# Analysts7

Ownership

Shares Out.63.58M

Float62.97M

Insiders0.86%

Institutions98.31%

Short Interest

Short Ratio5.0d

Short % Float3.47%

Short % Out.3.05%

Shares Short1.94M

Short (prev mo.)1.59M

Technical

SMA 50129.74 (-7.0%)

SMA 200126.78 (-4.9%)

Beta0.38

S&P 52W Chg14.58%

Avg Vol (30d)406.08K

Avg Vol (10d)420.04K

Technical Indicators

RSI (14)33.7

MACD-2.2142

MACD Signal-2.0022

MACD Hist.-0.2120

BB Upper126.87 USD

BB Middle123.49 USD

BB Lower120.10 USD

BB Width5.48%

ATR (14)2.316 USD

Vol Ratio (20d)0.94x